share_log

Illumina | 8-K: Current report

SEC announcement ·  Jan 9 13:00
Summary by Futu AI
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced its unaudited preliminary financial results for the fourth quarter and fiscal year ended December 31, 2023. The announcement was made in conjunction with the company's participation in the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024. Illumina reported a consolidated revenue of approximately $1,115 million for Q4 2023, marking a 3% increase from Q4 2022, and a total revenue of approximately $4,497 million for the fiscal year 2023, which is a 2% decrease from the previous year. The company's core revenue also saw a 2% increase in Q4 2023 compared to the same quarter in the previous year, but experienced a 3% decline for the full fiscal year. Illumina shipped a total of 79 NovaSeq X instruments in Q4 and 352 for the...Show More
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced its unaudited preliminary financial results for the fourth quarter and fiscal year ended December 31, 2023. The announcement was made in conjunction with the company's participation in the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024. Illumina reported a consolidated revenue of approximately $1,115 million for Q4 2023, marking a 3% increase from Q4 2022, and a total revenue of approximately $4,497 million for the fiscal year 2023, which is a 2% decrease from the previous year. The company's core revenue also saw a 2% increase in Q4 2023 compared to the same quarter in the previous year, but experienced a 3% decline for the full fiscal year. Illumina shipped a total of 79 NovaSeq X instruments in Q4 and 352 for the entire year. The GAAP operating margin for Q4 was reported at approximately (15.5%) and (24.0%) for the fiscal year, while non-GAAP operating margins were 3.8% for Q4 and 5.3% for the fiscal year. Core Illumina's GAAP operating margin stood at 2.4% for Q4 and 12.3% for the fiscal year, with non-GAAP operating margins at 18.0% for Q4 and 19.8% for the fiscal year. The company plans to report its full fourth quarter and fiscal year 2023 results on February 8, 2024, after market close. The preliminary results are subject to the completion of accounting and annual audit procedures and may be adjusted.

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.